Free Newsletter
Scientists say heparin tainted deliberately
Scientists are increasingly suspicious that the heparin scandal is a case of Chinese fakery. The contaminant found in recalled heparin batches appears to be a chemically altered version of chondroitin sulfate, the joint-pain supplement, that was mixed into real heparin deliberately. "A child could tell you it's counterfeiting," one expert told the New York Times. "This is a deliberate act of chemically manipulating a heparin-like substance with heparin to increase the yield.
But investigators haven't fingerprinted the contaminant exactly, and they haven't proven that it caused the severe allergic reactions--including deaths--linked to the tainted heparin; indeed, some tainted batches apparently didn't set off the reactions. Nor do the experts know who added it to the real thing, or when, or where.
More than a dozen top scientists are working to unravel the mystery. And to keep the mystery contaminant out of the U.S. drug supply, the FDA asked manufacturers to run sophisticated tests n their heparin products and ordered all untested heparin to be stopped at the border for analysis.
- read the story in the New York Times
Related Articles:
Heparin mimic found in suspect samples. Report
Germans ask for heparin testing. Report
FDA moves to allay drug-import fears. Report
China: Buyers on hook for drug safety. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: